Afresa: A New Insulin (By the Way, It’s Inhaled)

The enthusiasm for inhaled insulin has waned, to say the least, since Exubera was pulled off the market by Pfizer. Following the Exubera debacle, the development of two other inhaled insulins (AIR by Eli Lilly and Alkermes, and AERx by Novo Nordisk) was halted as well. But please don’t consider that the final word on inhaled insulin. There’s a new product in Phase III clinical

Read more